< Back to situations

[ORGANIZATION]

The BMJ

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [DE] [US] [GB]

GLP‑1 weight‑loss drugs linked to hair loss

2 clusters · 12 sources · last updated

Latest: Ozempic and Wegovy linked to increased hair loss

A study released on 24 July 2026 examined over 50,000 health records and found that users of the GLP‑1 medications semaglutide (Wegovy) and tirzepatide (Mounjaro) faced a markedly higher risk of alopecia—up to 70 % great

Also covered in